2023Clinical Infection in PracticeOpen access

Case report on cycloserine serum levels after treatment with oral terizidone and oral cycloserine

Lauren Rose, Jonathan Thompson, Louise Berry, Pradhib Venkatesan

Open full text 4 citations

Abstract

A 24 year old man with multi-drug resistant pulmonary tuberculosis was treated with a regime that included terizidone and then cycloserine. Serum drug levels of cycloserine were higher on milligram equivalent doses of cycloserine. Guidance implies that terizidone should be considered bioequivalent to cycloserine, but this case illustrates that this cannot be presumed. Any reduction in neuropsychiatric side-effects with terizidone may be due to lower cycloserine exposure and thereby reduced anti-mycobacterial efficacy.

About this research paper

What this paper is about

A 24 year old man with multi-drug resistant pulmonary tuberculosis was treated with a regime that included terizidone and then cycloserine. Serum drug levels of cycloserine were higher on milligram equivalent doses of cycloserine. Guidance implies that terizidone should be considered bioequivalent to cycloserine, but this case illustrates that this cannot be presumed. Any reduction in neuropsychiatric side-effects with terizidone may be due to lower cycloserine exposure and thereby reduced anti-mycobacterial efficacy.

Why it matters

OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

A 24 year old man with multi-drug resistant pulmonary tuberculosis was treated with a regime that included terizidone and then cycloserine. Serum drug levels of cycloserine were higher on milligram equivalent doses of cycloserine. Guidance implies that terizidone should be considered bioequivalent to cycloserine, but this case illustrates that this cannot be presumed. Any reduction in neuropsychiatric side-effects with terizidone may be due to lower cycloserine exposure and thereby reduced anti-mycobacterial efficacy.

Key concepts: Cycloserine, Pharmacology, Medicine, Drug, Internal medicine, Tuberculosis, Pathology

Related papers

Back to paper searchBrowse research topicsOriginal source
Case report on cycloserine serum levels after treatment with oral terizidone and oral cycloserine — Research Paper | ScholarLens